Article Information
History
- January 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Jessie R Chung1,*,
- Sara S Kim1,
- Edward A Belongia2,
- Huong Q McLean2,
- Jennifer P King2,
- Mary Patricia Nowalk3,
- Richard K Zimmerman3,
- Krissy Moehling Geffel3,
- Emily T Martin4,
- Arnold S Monto4,
- Lois E Lamerato5,
- Manjusha Gaglani6,7,
- Eric Hoffman6,
- Marcus Volz6,
- Michael L Jackson8,
- Lisa A Jackson8,
- Manish M Patel1 and
- Brendan Flannery1
- 1Centers for Disease Control and Prevention, Atlanta, GA, USA
- 2Marshfield Clinic Research Institute, Marshfield, WI, USA
- 3University of Pittsburgh Schools of the Health Sciences and University of Pittsburgh Medical Center, Pittsburgh, PA, USA
- 4University of Michigan, Ann Arbor, MI, USA
- 5Henry Ford Health System, Detroit, MI, USA
- 6Baylor Scott and White Health
- 7Texas A&M University College of Medicine, Temple, TX, USA
- 8Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA
- ↵*Corresponding Author:
Jessie Chung, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-7, Atlanta, Georgia, 30329 (jchung{at}cdc.gov, (404) 639-2696).
Posted January 01, 2022.
Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021
